联邦制药:盈利警告

香港交易所
Mar 12

牛牛AI助手已提取核心信息联邦制药发布盈利警告,预计截至2025年12月31日止年度将录得溢利约人民币20亿元,较2024年度约人民币26.58亿元下降。溢利下滑主要由于年内中间体产品及原料药的市场价格下跌,导致这两个分部溢利分别减少约人民币16亿元及4亿元。然而,制剂产品分部表现亮眼,溢利大幅上升约人民币14亿元,其中来自诺和诺德的许可费收入贡献约人民币13亿元,部分抵消了其他分部的溢利下降。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10